This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.
This webinar will address current concepts in the realm of cell free DNA testing for cancer, with an emphasis on the role of plasma-based testing in patients with non-small cell lung carcinoma. Topics to be covered include: the process for validating and implementing cfDNA testing in the hospital setting, the clinical role for cfDNA testing in cancer patients with an emphasis on EGFR-mutated lung carcinoma, and approaches to next-generation sequencing for cfDNA. Practical issues will be emphasized, including clinical performance characteristics of available assays and specimen handling considerations. Selected studies demonstrating the future potential of cfDNA testing for cancer monitoring will be reviewed.
Speaker: Lynette M. Sholl, MD
Host: Anthony Snow, MD
Duration: 1 hr
Level of Instruction: Basic
If you would like continuing education credit, click on the links below.
* You may not submit SAMs and CME/CMLE credit for the same content.
Note: Members of AMP can access this webinar at no cost. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
September 25, 2017
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $195.00